APOA4

APOA4, or apolipoprotein A-IV, is a vertebrate protein encoded by the APOA4 gene in humans. It is a component of circulating lipoproteins, predominantly associated with chylomicrons and high-density lipoproteins, and is considered part of the apolipoprotein family involved in lipid transport.

Expression and localization: The APOA4 gene is mainly expressed in the small intestine, especially in enterocytes. The protein is synthesized and secreted into the lymph as part of chylomicrons during dietary fat absorption and subsequently appears in plasma after meals.

Function: Apolipoprotein A-IV participates in lipid metabolism by contributing to chylomicron assembly and maturation and may help regulate triglyceride clearance, potentially through interactions with lipoprotein lipase and lipoprotein remodeling. In addition, animal studies have suggested roles in appetite regulation and glucose homeostasis, though the extent of these effects in humans remains to be clarified. Overall, APOA4 is involved in postprandial lipid handling rather than serving as a major structural lipoprotein.

Clinical significance: Variants in APOA4 have been investigated for associations with plasma triglyceride and HDL cholesterol levels and with cardiovascular disease risk. Findings across studies and populations have been inconsistent, and no common APOA4 variant has a confirmed large effect on disease risk. Ongoing research explores its metabolic functions and potential therapeutic implications.

Genomic context: APOA4 is located among apolipoprotein genes on chromosome 11 in humans and is conserved across mammals, reflecting a role in lipid transport and metabolism.